揚傑科技(300373.SZ):奮鬥者計劃(一期)員工持股計劃股票出售完畢暨計劃終止
格隆匯 3 月 17日丨揚傑科技(300373.SZ)公佈,截至公吿日,“奮鬥者計劃(一期)”員工持股計劃所持有的236.96萬股公司股票已通過集中競價方式全部出售完畢。在實施此次員工持股計劃期間,公司嚴格遵守中國證券監督管理委員會及深圳證券交易所關於信息敏感期不得買賣股票的規定,未利用任何內幕信息進行交易。
截至公吿日,此次員工持股計劃所持公司股票已全部出售完畢,所持資產均為貨幣資產。根據《揚州揚傑電子科技股份有限公司“奮鬥者計劃(一期)”員工持股計劃(草案修訂稿)》的有關規定,此次員工持股計劃已實施完畢並將提前終止,後續將進行相關資產清算和分配工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.